Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

To assess the levels of loteprednol etabonate (LE) in tear fluid following a single topical instillation of LE ophthalmic gel 0.5% formulation to healthy volunteers.

Key facts

Study ID
NCT01736527
Run by
Bausch & Lomb Incorporated
People needed
12
Starts
2013-01-01
Expected to finish
2013-04-01
Last updated by the study team
2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.